After open public discussion and a unanimous board vote, Tri-City Healthcare District (“Tri-City” or “District”) announced yesterday that UC San...
This centuries old martial art was shown to reduce the severity of symptoms in the long-term.
PTC Therapeutics has delayed its plans by nine months to apply for FDA approval of its treatment for phenylketonuria, a rare disease that causes protein...
A significant proportion of cancer patients do not succumb to the initial tumor but rather to the resulting metastases. The growth of these secondary cancer...
At the recommended Phase II dose of 5x1011 particle units, six of 12 patients (50%) receiving PRGN-2012 achieved a complete response by no longer needing...
Among a slew of emerging artificial intelligence biotech companies, BigHat has the potential to transform how next-generation antibodies are designed,...
Johnson & Johnson’s first-ever clinical study in psoriasis with patients of color found its treatment Tremfya works similarly across diverse populations,...
It’s the day after the Baltimore Orioles clinched the American League East Championship with their 100th win of the season, and lifelong fan Tim Evans...
The Global Coalition for Adaptive Research (GCAR) in collaboration with the University of Pittsburgh and UPMC, on behalf of the REMAP-CAP Investigator...
Three pharmaceutical stocks to purchase for promising products poised to profit. The three pharmaceutical stocks purchase stand out even though that sector’s...
Following a national search, Paul Anderson, MD, PhD, has been named Chief Academic Officer for Mass General Brigham. Anderson, who has been serving in...
Heartland BioWorks, which has assembled partners that bring together biotech and manufacturing research and resources, will focus on the development of...
The Alliance for Clinical Trials in Oncology today announced detailed results will be presented at ESMO 2023 from CABINET (A021602), a phase III pivotal...
The team developed a computational metabolite exchange scoring system to identify microbial cross feeding relationships--the use of metabolites produced...
Executives from clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine will present on the impact of AI on biotechnology...
Researchers developed a technology called TEMPO, which integrates microvolume liquid-biopsy proteomics, single-cell transcriptomics, and AI, to map almost...
The number one thing most people fear as they age is developing dementia. As the world’s population becomes increasingly older, this is a growing public...
Digital health tools and technologies were thrust into the spotlight during the pandemic and were able to help many people get much needed medical advice...
Digitization of clinical trials isn’t particularly new. Today, electronic data capture is only one of myriad technologies deployed in clinical trials...
In this GEN webinar, Dr. Shelby Wyatt from Flywheel will discuss how AI-based medical imaging helps imaging/data scientists, innovators, and healthcare...
Laronde and Senda Biosciences, two biotech startups founded by Flagship Pioneering that collectively raised more than $750 million, are merging to form...
What Some Call "Anti-Science" Is Just Anti-Authoritarianism Authored by Alex Washburne via The Brownstone Institute, Sometimes it feels...
Cytiva and Bayer share a vision of the challenges limiting the advancement of allogeneic cell therapy and believe that together they can overcome these...
Generative AI is a new and rapidly emerging form of artificial intelligence that has the potential to revolutionize precision medicine by improving diagnosis,...
A newly launched, first-of-its-kind institute aims to address a glaring gap in the medical system by working to integrate food-based nutrition interventions...
MIAMI, FLORIDA (Oct. 18, 2023) – Stephen D. Nimer, MD, director of Sylvester Comprehensive Cancer Center at the University of Miami Miller School of...
The goal of mRNA technology is to harness the power of the cell to potentially prevent infections and treat diseases.
By William Haseltine Regenerative medicine has emerged as a promising treatment option for chronic medical conditions. Specifically, cell and gene therapies,...
The University of Cincinnati Cancer Center has joined the National Cancer Institute’s Experimental Therapeutics Clinical Trials Network (ETCTN), providing...
Some viruses can be dormant throughout a person’s life and cause no harm but become dangerous when the immune system is weakened. One of such viruses...